Autobio Diagnostics Co., Ltd. Stock
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.47 CNY | +1.18% |
|
+5.14% | -18.49% |
| Nov. 26 | Autobio Diagnostics Gets Registration Certificates for Five Medical Devices | MT |
| Oct. 25 | Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 26.59B 3.67B 3.48B 3.24B 2.89B 5.14B 310B 5.64B 40.08B 14.92B 127B 13.79B 13.48B 552B | P/E ratio 2024 * |
20.1x | P/E ratio 2025 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise value | 26.59B 3.67B 3.48B 3.24B 2.89B 5.14B 310B 5.64B 40.08B 14.92B 127B 13.79B 13.48B 552B | EV / Sales 2024 * |
5.59x | EV / Sales 2025 * | 4.73x |
| Free-Float |
29.86% | Yield 2024 * |
2.54% | Yield 2025 * | 2.99% |
More valuation ratios
* Estimated data
More news
| 1 day | +1.18% | ||
| 1 week | +5.14% | ||
| 1 month | +3.29% | ||
| 3 months | +13.79% | ||
| 6 months | -9.40% | ||
| Current year | -18.49% |
1 week
44.10
47.08
1 month
44.1047.82
Current year
37.5666.36
1 year
37.5666.36
3 years
37.5681.00
5 years
37.56139.22
10 years
13.46139.22
| Director | Title | Age | Since |
|---|---|---|---|
Zeng Li Yang
CEO | Chief Executive Officer | 56 | 2018-10-28 |
Chao Jie Feng
DFI | Director of Finance/CFO | 46 | 2012-11-12 |
Wei Liu
ADM | Chief Administrative Officer | 48 | 2005-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Xun Zhang
BRD | Director/Board Member | 59 | 2005-12-31 |
Xue Wei Wu
BRD | Director/Board Member | 57 | 2002-12-31 |
Guang Yu Fu
BRD | Director/Board Member | 55 | 2012-11-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.56% | 1 M€ | -20.08% | - | |
| 0.03% | 35 M€ | -5.85% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.18% | +5.14% | -9.50% | -16.99% | 3.67B | ||
| -0.20% | +0.15% | +0.09% | -21.05% | 12.31B | ||
| +2.85% | +5.64% | -6.96% | +34.62% | 7.09B | ||
| -1.11% | -1.38% | +24.64% | +233.35% | 6.21B | ||
| +0.24% | -1.54% | +21.69% | -43.95% | 5.95B | ||
| +1.45% | +9.07% | +41.48% | -66.12% | 4.4B | ||
| -0.53% | +1.54% | +23.31% | -59.28% | 2.79B | ||
| +0.84% | -1.75% | +16.92% | +128.16% | 2.76B | ||
| +2.71% | +11.11% | -63.47% | -89.59% | 1.92B | ||
| +0.83% | -2.27% | +17.96% | -43.31% | 1.74B | ||
| Average | +0.83% | +2.74% | +6.62% | +5.58% | 4.88B | |
| Weighted average by Cap. | +0.62% | +2.19% | +8.23% | +15.57% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 4.75B 656M 622M 579M 517M 920M 55.52B 1.01B 7.17B 2.67B 22.77B 2.47B 2.41B 98.79B | 5.62B 776M 736M 684M 611M 1.09B 65.65B 1.19B 8.47B 3.16B 26.93B 2.92B 2.85B 117B |
| Net income | 1.35B 186M 176M 164M 146M 261M 15.73B 286M 2.03B 756M 6.45B 699M 683M 27.99B | 1.65B 229M 217M 202M 180M 320M 19.33B 351M 2.49B 929M 7.93B 858M 839M 34.39B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,539
Calendar
2025-04-17
- Q1 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-11-29 | 46.47 ¥ | +1.18% | 2,342,388 |
| 24-11-28 | 45.93 ¥ | -1.12% | 2,618,110 |
| 24-11-27 | 46.45 ¥ | +2.77% | 3,583,950 |
| 24-11-26 | 45.20 ¥ | +1.25% | 2,018,280 |
| 24-11-25 | 44.64 ¥ | +1.00% | 2,279,190 |
End-of-day quote Shanghai S.E., November 28, 2024
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
46.47CNY
Average target price
58.57CNY
Spread / Average Target
+26.05%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 603658 Stock